Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

New kinetic model for a minimal cell helps to quantitatively understand the principles of life

Feb. 7, 2022

Researchers present single-cell atlas of the normal and malformed brain vasculature

Feb. 4, 2022

New DDR1 and/or DDR2 inhibitors identified at Galapagos

Feb. 2, 2022

Low penetrance of deleterious genetic variants observed in large cohorts

Jan. 28, 2022

Sichuan Haisco Pharmaceutical discloses new JAK inhibitors

Jan. 24, 2022

Medshine Discovery identifies new NLRP3 inflammasome inhibitors

Dec. 31, 2021

British Pakistani genomics study illustrates need for diversity

Dec. 24, 2021

Medshine Discovery identifies new CCR5/CCR1 antagonists

Dec. 10, 2021

MALT1 mutant mice reveal role of E3 ligase TRAF6 in peripheral immune tolerance

Dec. 2, 2021

Ube Industries patents integrin alphav antagonists

Dec. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...